Different cancers of the eye and their survival rate

On Behalf of | May 28, 2020 | Medical Malpractice

Cancer of the eye may be rare, but residents of Texas should still be aware of it. An estimated 3,400 U.S. adults will likely be diagnosed with eye cancer in 2020, specifically primary intraocular cancer. By “primary” is meant that the cancer starts in the eye. Secondary eye cancer, which is more common, starts elsewhere and spreads to the eye.

Of those cases of primary intraocular cancer that will probably arise, most are projected to be melanoma. Various types of this cancer exist. For example, one of the rarest is iris melanoma, which hardly spreads and has a five-year survival rate of 95%.

Another rare type is ciliary body melanoma, which affects the uvea, or colored part, of the eye. Choroidal melanoma, which arises in the choroid, a membrane at the back of the eye, is the most common. The five-year survival rate for large choroidal melanoma is 47%. When it comes to eye cancers in general, the five-year survival rate is 80% or, if the cancer is detected early, 85%. It has been predicted that 210 men and 180 women will die in 2020 from primary intraocular cancer.

About 73% of eye cancer patients are diagnosed at an early stage. Some types of cancer can be hard to detect, but others may slip by unnoticed because of negligence on the part of doctors. Those who are harmed through such negligence may have a case under medical malpractice law since they should not be responsible for the medical expenses and other losses they incurred. With a lawyer, they may be able to file a strong claim and negotiate for a fair settlement.